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Lecture Given At the EPA’s National ConferenceAims
Introduce new concepts and changes in neonatal
resuscitation.
Discuss hypothermia as an addition for treatment for neo-
natal hypoxic–ischemic encephalopathy.
Explain new ideas about role of probiotics in enhancing
neonatal immunity.
Update in retinopathy of prematurity.
Better understanding of neonatal thrombocytopenia.
1. New concepts and changes in neonatal resuscitation
(2010 International Consensus on Cardiopulmonary
Resuscitation)
1.1. Changes to the Neonatal Resuscitation Program (NRP)
1.1.1. Assessment of cardiorespiratory transition and need for
resuscitation
There is clear evidence that an increase in oxygenation and
improvement in color may take several minutes to achieve,
even in uncompromised babies.
Furthermore, there is increasing evidence that exposure of
the newborn to hyperoxia is hazardous to many organs at
a cellular and functional level.
For this reason, color has been removed as an indicator of
oxygenation or resuscitation efﬁcacy.
The oximeter should be used to adjust the level of
oxygenation.
 Heart rate is the primary vital sign to judge the need for
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mary mean for assessment of heart rate.
 For babies who require ongoing resuscitation or respira-
tory support or both, the goal should be to use pulse
oximetry.
 Pulse oximetry is used in conjunction with and should
not replace clinical assessment of heart rate during
neonatal resuscitation.
1.1.2. Oxygen use in neonatal resuscitation
In full term infants:
 In term infants receiving resuscitation at birth with positive
pressure ventilation, it is better to start with air rather than
100% oxygen. If despite effective ventilation, there is no
increase in heart rate or if oxygenation (guided by oximetry)
remains unacceptable, use of a higher concentration of
oxygen should be considered.
 If resuscitation is started with less than 100% O2, assess-
ment of improvement after 90 s should be done and if no
improvement, then 100% O2 should be given.
1.1.3. Meconium suctioning at perineum
 There is no evidence to support suctioning of the mouth
and nose of depressed neonates at birth when the infant is
born through clear amniotic ﬂuid.
 In healthy neonates, suctioning of the mouth and nose
could be associated with cardiorespiratory complications.
 It is no longer recommended that all meconium stained
infants routinely receive intrapartum suctioning.
s Large randomized controlled trial with 2514 babies of at
least 37 week gestation showed that.
s No beneﬁt to routine suctioning before delivery of
shoulders.
s Suctioning does not prevent meconium aspiration
syndrome.he Egyptian Pediatric Association.
Hot topics in neonatology 93 The available evidence does not support the routine endo-
tracheal suctioning of depressed infants born with meco-
nium-stained amniotic ﬂuid.
1.1.4. Ventilation strategies
Initial breaths
To establish initial lung inﬂation in apneic newborn infants, initi-
ation of intermittent positive-pressure ventilation at birth can be
accomplished with either shorter or longer inspiratory times.
Initial peak inﬂating pressures necessary to achieve an in-
crease in heart rate or movement of the chest are variable
and unpredictable and should be individualized with each case.
If pressure is being monitored, an initial inﬂation pres-
sure of 20 cm H2O may be effective in preterm babies, but
a pressure of 30–40 cm H2O may be necessary in some term
babies.
If pressure is not being monitored, the minimal inﬂation re-
quired to achieve an increase in heart rate, should be used.
Providers should avoid creation of excessive chest wallmovement
during ventilation of preterm infants immediately after birth.
1.1.5. Continuous positive airway pressure
Spontaneously breathing preterm infants who have respiratory
distress may be supported with CPAP or intubation and
mechanical ventilation.
The most appropriate choice may be guided by local exper-
tise and preferences.
1.1.6. Devices for assisting ventilation
T-piece CPAP delivery devices are now recognized as another
method of delivering effective ventilation during resuscitation.
Anesthesia and self inﬂating bags still are the primary
modes of resuscitation.
CPAP devices do not work if the newborn is apneic.
1.1.7. Use of exhaled CO2 detectors to conﬁrm tracheal tube
placement
Detection of exhaled CO2 in addition to clinical assessment is
recommended as the most reliable method to conﬁrm endotra-
cheal placement in neonates with spontaneous circulation.
1.1.8. Chest compressions
 Chest compressions in the newborn should be delivered by
the 2 thumb–encircling hands method as the preferred
option.
 Compressions should be centered over the lower third of the
sternum and should compress the chest one third of the
anterioposterior diameter.
 Any chest compressions should be performed in combina-
tion with adequate inﬂation breaths.
1.1.9. Medications
 Epinephrine
s If adequate ventilation and chest compressions have
failed to increase the heart rate to 60 beats per minute,
then it is reasonable to use epinephrine.s If epinephrine is indicated, a dose of 0.01–0.03 mg/kg
should be administered intravenously as soon as
possible.
 Volume expansion
Early volume replacement with crystalloid or red cells is
indicated for babies with blood loss who are not responding
to resuscitation.
There is insufﬁcient evidence to support the routine use of
volume administration in infants with no blood loss who
are refractory to ventilation, chest compressions, and
epinephrine.
Because blood loss may be occult, a trial of volume admin-
istration may be considered in babies who do not respond
to resuscitation.
 Naloxone
Naloxone is not recommended as part of the initial resusci-
tation for newborns with respiratory depression in the
delivery room.
For the clinical situation of a newborn with respiratory
depression after maternal opiate exposure, the focus needs
to remain on effective ventilation and airway support for
the persistently apneic newborn.
1.1.10. Vascular access
Temporary intraosseous access to provide ﬂuids and medica-
tions to resuscitate critically ill neonates may be indicated fol-
lowing unsuccessful attempts to establish intravenous vascular
access or when caregivers are more skilled at securing intraos-
seous access.
1.1.11. Temperature control
Premature infants need more than what radiant warmers
provide.
There is increased evidence to support wrapping of infants
less than 30 weeks to prevent rapid loss of body heat.
Those at high risk for hypoxic injury may beneﬁt from
decreased warming during resuscitation.
Delivery room temperature should be at least 26 C for
infants of 28 weeks’ gestation.
1.1.12. Timing of cord clamping
 Delay in umbilical cord clamping for at least 1 min is rec-
ommended for newborn infants not requiring resuscitation.
 There is insufﬁcient evidence to support delay of cord
clamping in babies requiring resuscitation.
2. Recent concepts about hypothermia as a treatment for
neonatal hypoxic ischemic encephalopathy
 Neonatal Hypoxic Ischemic Encephalopathy (HIE) is deﬁned
as a neonatal encephalopathy due to hypoxic-ischemic
brain injury.
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s Moderate encephalopathy carries 10% mortality and
30% risk of severe disability for survivors.
s Severe encephalopathy carries 60% mortality with
nearly 100% severe neurological morbidity in
survivors.
 Studies have shown that hypoxic ischemic injury can be
reduced by brain cooling with favorable effect on many of
the pathways contributing to brain injury as:
s Excitatory amino acids,
s Cerebral energy state,
s Cerebral blood ﬂow and metabolism,
s Nitric oxide production,
s Apoptosis.
 Brain can be cooled by cooling the body or the head
selectively.
s Whole body cooling provides homogeneous cooling of
all brain structures both peripheral and central.
s Selective head cooling provides greater cooling to the
periphery of the brain.
 Most effective when applied and restricted to secondary
phase of HI injury.
 Animal studies show rebound effect if cooling is terminated
at either 24 or 48 h.
 No rebound noted after 72 h.
 No signiﬁcant differences in adverse events, between control
and hypothermic infants, were detected in either of the large
trials.
 More studies need to be conducted before widespread appli-
cability and safety can be ascertained.3. New ideas about the role of Probiotics in enhancing neonatal
immunity
3.1. Neonatal intestinal ﬂora
Newborn intestinal tract is nearly sterile at birth.
Colonization occurs in the ﬁrst 12-24 hours after birth.
First organisms are Escherichia coli and enterococci.
Shortly thereafter anaerobes begin to predominate.
Preterm intestine tends to be colonized with different
organisms than the term infant.3.2. Alteration of the normal ﬂora
Delay in normal colonization occurs due to:
s Infection control measures,
s Reduced exposure to maternal bacteria,
s Sterile feeds,
s Incubators,
s Antibiotic use.3.3. Immune response at birth is still immature
Immature immune response at birth especially in preterm in-
fants is due to:Loose physical structure of the intestinal wall (increased
permeability).
Acquired immune response not yet trained to recognize
pathogens (insufﬁcient production of IgA).
T-helper cells response skewed toward Th-2 response
(allergy).
3.4. Why is the gut micro ﬂora considered as an important
element of the gastrointestinal immune system?
They seal the gaps between epithelial cells and thus decrease
permeability of the mucosa to antigens.
They stimulate secretion of S IgA in Peyer’s patches and con-
sequently help in promoting a balanced immune response.
The beneﬁcial bacteria inhibit the overgrowth of disease-
causing microorganisms.
3.5. Probiotics
 From the Greek meaning ‘for life’.
 Probiotic bacteria are live microbial supplements that colo-
nize the intestine and provide beneﬁt to the host.
 Friendly bacteria supplement which have a positive effect
on the maintenance of a healthy intestinal tract.
 Members of the Probiotics
s Lactobacilli: Lactobacillus acidophilus & Lactobacillus
rhamnosus.
s Biﬁdobacteria: Biﬁdobacterium biﬁdum
 Functions of Probiotics
s Enhance the body’s immune system,
s Produce important nutrients,
s Destroy bad bacteria and eliminate toxins,
s Protect food from putrefaction,
s Synthesize vitamins,
s Anti carcinogenic activity in clinical trials.
 Two possible strategies:
s Dietary modulation of intestinal ﬂora ‘‘Biﬁdogenic
effect’’ To create optimal conditions for growth of
biﬁdobacteria/lactobacilli.
s Supplementation with Probiotics.4. Recent understanding of Retinopathy of prematurity
It is deﬁned as an abnormal retinal vasculogenesis. It is a
serious vasoproliferative disorder affecting the eyes of the pre-
mature babies due to an abnormal retinal vascularization. It is
one of the most common causes of blindness in children.
Today, it is believed to be the leading cause of blindness in
American children, greater than all the other causes combined.
4.1. Pathophysiology
The blood supply to the retina starts at 16 weeks of gestation
from the optic disk.
The vessels grow gradually outward from the optic disk
toward the nasal and temporal periphery of the retina.
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creases progressively. The blood vessels reach the anterior edge
of the retina and stop their progression at about the time of
birth.
In premature infants, the normal growth of the retinal
blood vessels stops and becomes incomplete.
As the human fetus lives in an environment of low oxygen-
ation PaO2 in the umbilical vein ranges from 25 to 35 mmHg.
At preterm birth, the baby is taken out of his protective
uterine environment and his retina is exposed to relative hyper-
oxygenation, even if no supplemental oxygen is given.
Unfortunately, a few cases progress to yield an exudative
response which when organized leads to the formation of scar
tissue between the retina and vitreous. When this scar tissue
shrinks and contracts, it pulls on the retina and produces a
tractional retinal detachment.
4.2. Criteria for screening
There are no universally accepted screening criteria and each
NICU must decide its own standards.
 WHO?
s Infants <1800 gm or <35 w G.A with O2 therapy.
s Infants <1500 gm or <30 w G.A with or without O2
therapy.
s If the neonatologist feels that there is an increased risk for
any baby in the NICU regardless his weight or G.A, he
should ask for eye examination.
WHEN?
The timing of the initial examination is also open to debate.
However, there is good evidence that the time of onset of ROP
is more closely related to the gestational age than the chrono-
logical age.
Initial examination should be done at:
s 33 weeks of gestational age or
s 4–6 weeks after birth.
Follow Up
Subsequent examinations are done every 2 weeks until
retinal vessels are mature to the retinal edge.
In cases with actively progressing ROP, examination may
be needed every week.
Long term follow up should be done within 6–12 months.
5. Better understanding of neonatal thrombocytopenia
5.1. Incidence of thrombocytopenia is 18–35% of the NICU
population:
5.2. Causes of Thrombocytopenia
A. According to the pathophysiology:
 Immune mediated
s Alloimmune
s Autoimmune (Isoimmune) Infections mediated
s (Bacterial, Fungal and Viral)
 Genetics mediated
 Drug related
 Other causes
B. According to the mechanism:
 Decreased or impaired platelet production (75% of cases)
 Increased platelet destruction and/or sequestration
 Combined mechanisms
C. According to time of presentation:
 Early Neonatal Thrombocytopenia (onset <72 h after
birth’
s Placental insufﬁciency
s Perinatal asphyxia
s DIC
s Alloimmune
s Autoimmune
 Late Neonatal Thrombocytopenia (onset >72 h of life)
s Late onset sepsis
s NEC
s Thrombosis
s Congenital infection (CMV, Toxoplasma, etc)
5.3. Guidelines for platelet transfusion thresholds for
neonates
Platelet count
(·109/l)
Non- bleeding
neonate
Bleeding neonate
<30 Consider transfusion
in all patients
Transfuse
30–49 Consider transfusion
if:
Transfuse
<1000 g or
<1 week age
Clinically unstable
Previous major
bleeding (Grade 3–4
IVH)
Current minor
bleeding
Needs surgery or
exchange
transfusion
50–99 Do not transfuse Transfuse
>99 Do not transfuse Do not transfuse
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